Latest
Asymptomatic C diff Associated With Pathogen Reservoir, Affecting Carriers, Patients, Employees in ICU
FDA Wants More Data on Viaskin Peanut Allergy Patch
Patients’ Expectations of Palliative Chemotherapy Unchanged by Educational Intervention
Pediatric Fecal Viral Shedding Examined as Route of COVID-19 Transmission
GII.4 Genotype Most Common in Sporadic Pediatric Acute Gastroenteritis
Fecal Transplantation Associated With Improvements in IBS Symptoms
PAs and Gastroenterologists Proven Equally Capable of Performing Colonoscopies
Utility of Intracystic Glucose for Diagnosis of Mucinous, Non-Mucinous Pancreatic Cysts Examined
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile in Cirrhosis
Early Rebleeding Following Endoscopic Variceal Ligation Associated With Increased Mortality Risk
Ortikos Now Available for Mild to Moderate Crohn Disease
Women at Lower Risk for Nonalcoholic Fatty Liver Disease But at Greater Risk for Progression
Discontinuation of Anti-TNF Agents More Likely in Patients With IBD Plus Anxiety, Mood Disorders
Zenocutuzumab Gets Orphan Drug Designation for Pancreatic Cancer
Periodontal Disease, Tooth Loss Linked to Esophageal, Gastric Cancer
Are There Sufficient Data to Confirm a Protective Role for Anti-TNF in COVID-19?
Clinical Hold Lifted on Seladelpar for Chronic Liver Diseases
CDC Guidance Issued for Testing, Management of Healthcare Personnel Exposed to Hepatitis C
Study Finds Primary Precut Sphincterotomy Better Than Early Precut for Preventing Post-ERCP Pancreatitis
Featured Content
-
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes. -
Proton Pump Inhibitors and COVID-19: Is There an Increased Risk?
A team of investigators assessed the potential for use of proton pump inhibitors to affect the risk of COVID-19 infection. -
Updates on NAFLD: Is FMT the Treatment of the Future?
As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option. -
PPI Use and Dementia Development: Is There a Link?
PPIs are frequently used off-label and are easily accessible as over-the-counter products, contributing to the potential for adverse events or drug-drug interactions. -
Diagnosing and Managing Patients With Primary Pancreatic Lymphoma
Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established.
Ulcerative Colitis and Fecal Transplantation: Where are We Now?
It is thought that dysregulation of the gut microbiome could cause increased production of pro-inflammatory toxins that can predispose patients to the development of UC.
Liver Forum Releases Recommendations on Diet, Exercise in NAFLD/NASH
The lack of standardized diet and exercise recommendations across NAFLD/NASH clinical trials has posed a significant challenge in understanding their impact.
Texture Analysis may Distinguish Between Types of Abnormal Computed Tomography Scans
Texture analysis of CT scan images may provide useful quantitative information to aid in differentiating between several types of gastrointestinal lesions.
Fecal Shedding of SARS-CoV-2 Outlasts That of Respiratory Tract
A timeline for fecal viral shedding of COVID-19 has been published in Gastroenterology.
Predictors of Benign Pathology in Patients with Proximal Biliary Structures
Researchers identified abdominal pain, low serum carbohydrate antigen (CA) 19.9 levels, and absence of mass on imaging as independent predictors of benign lesions in patients with proximal biliary strictures (PBS), as indicated by study data published in HPB. According to the researchers, the aforementioned risk factors may be used to differentiate benign lesions from perihilar…
-
Loading...
-
Loading...
